LRRFIP1 Antibody Blocking Peptide

Product Discontinued

LRRFIP1 Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 19 amino acid peptide near the carboxy terminus of human LRRFIP1.

  Source: Synthetic

  (Accession #: NP_001131022)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: LRRFIP1
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-76545.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for LRRFIP1 Antibody Blocking Peptide

• FLAP-1
• FLIIAP1
• GC-binding factor 2
• GCF2
• GCF-2
• HUFI-1
• leucine rich repeat (in FLII) interacting protein 1
• leucine-rich repeat flightless-interacting protein 1
• LRR FLII-interacting protein 1
• MGC10947
• MGC119738
• MGC119739
• NEDD8-conjugating enzyme
• TRIPTAR RNA-interacting protein

Background

Transcriptional repressor which preferentially binds to the GC-rich consensus sequence (5'-AGCCCCCGGCG-3') and may regulate expression of TNF, EGFR and PDGFA. May control smooth muscle cells proliferation following artery injury through PDGFA repression. May also bind double-stranded RNA

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: LRRFIP1